Cystic fibrosis is a condition which mainly affects the lungs and pancreas, but can affect other parts of the body, including the liver, nose and sinuses, reproductive organs, and sweat glands. Our Cystic Fibrosis testing is performed using massive parallel sequencing (next generation sequencing) which allows for the analysis of exons, intron-exon boundaries, and UTRs that contain common mutations in the CFTR gene. This methodology with sequence analysis of all exons, intron/ exon borders, promoter regions, and specific intronic regions detects more than 98% of CFTR mutations.
